J Frontier Co., Ltd. (JP:2934)
:2934
Want to see JP:2934 full AI Analyst Report?
2934 Stock Chart & Stats
¥1326.00
¥89.00(6.94%)
At close: 4:00 PM EST
¥1326.00
¥89.00(6.94%)
Day’s Range― - ―
52-Week Range¥1,196.00 - ¥2,050.00
Previous CloseN/A
Volume44.20K
Average Volume (3M)40.58K
Market Cap
¥9.25B
Enterprise Value¥11.94B
Total Cash (Recent Filing)¥2.17B
Total Debt (Recent Filing)¥4.34B
Price to Earnings (P/E)6.4
Beta0.94
Next Earnings
Jul 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)17.79
Shares Outstanding5,333,465
10 Day Avg. Volume58,880
30 Day Avg. Volume40,583
Financial Highlights & Ratios
PEG Ratio-0.89
Price to Book (P/B)5.74
Price to Sales (P/S)0.38
P/FCF Ratio18.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Free Cash Flow ImprovementReported improvement in free cash flow growth provides a durable source of internal funding that can support capex, working capital and debt repayment over the medium term. Sustained FCF improvement increases financial flexibility even if operating cash flow remains uneven.
Stable Gross Profit MarginA relatively stable gross margin indicates the company maintains underlying product/service pricing power and cost control at the production level. That stability supports margin sustainability and helps buffer operating profit volatility if revenues recover or stabilize.
Exposure To Healthcare Information ServicesOperating in healthcare information services ties the business to structural demand for digital health, data services and wellness solutions. Durable industry tailwinds support long-term revenue opportunity and client stickiness versus cyclical sectors over 2-6 months and beyond.
Bears Say
Sharp Revenue DeclineA roughly 69% year-over-year revenue contraction is a material structural weakness that impairs scale economics, weakens pricing leverage and impedes reinvestment. Restoring top-line growth is essential for sustainable margins and long-term recovery of profitability.
High LeverageElevated debt-to-equity increases financial risk and interest burden, limiting strategic flexibility to invest or absorb shocks. High leverage makes deleveraging and sustainable margin recovery more critical, constraining the company’s capacity to fund growth from operations.
Inconsistent Operating Cash Flow & Volatile Net MarginsInconsistent operating cash flow and a negative OCF-to-net-income ratio show weak earnings quality and cash conversion. Coupled with volatile net margins, this undermines the company’s ability to fund working capital and sustain investment without external financing.
2934 FAQ
What was J Frontier Co., Ltd.’s price range in the past 12 months?
J Frontier Co., Ltd. lowest stock price was ¥1196.00 and its highest was ¥2050.00 in the past 12 months.
What is J Frontier Co., Ltd.’s market cap?
J Frontier Co., Ltd.’s market cap is ¥9.25B.
When is J Frontier Co., Ltd.’s upcoming earnings report date?
J Frontier Co., Ltd.’s upcoming earnings report date is Jul 10, 2026 which is in 53 days.
How were J Frontier Co., Ltd.’s earnings last quarter?
J Frontier Co., Ltd. released its earnings results on Apr 14, 2026. The company reported ¥52.32 earnings per share for the quarter, beating the consensus estimate of N/A by ¥52.32.
Is J Frontier Co., Ltd. overvalued?
According to Wall Street analysts J Frontier Co., Ltd.’s price is currently Overvalued.
Does J Frontier Co., Ltd. pay dividends?
J Frontier Co., Ltd. does not currently pay dividends.
What is J Frontier Co., Ltd.’s EPS estimate?
J Frontier Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does J Frontier Co., Ltd. have?
J Frontier Co., Ltd. has 5,333,465 shares outstanding.
What happened to J Frontier Co., Ltd.’s price movement after its last earnings report?
J Frontier Co., Ltd. reported an EPS of ¥52.32 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.062%.
Which hedge fund is a major shareholder of J Frontier Co., Ltd.?
Currently, no hedge funds are holding shares in JP:2934
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
J Frontier Co., Ltd.
J Frontier Co.,Ltd. engages in the healthcare sale, medical care sale, and healthcare marketing businesses in Japan. It is involved in various activities, including online medical care, medication guidance, as well as operates drug delivery platform, medical institutions, and operates dispensing pharmacy. The company engages in distribution of pharmaceuticals products as well as involved in marketing, logistics, and call center activities. J Frontier Co.,Ltd. was incorporated in 2008 and is based in Tokyo, Japan.